Panacea Index Logo

Command Palette

Search for a command to run...

Treatment of difficult-to-treat depression - clinical guideline for selected interventions.

Nordic journal of psychiatry
April 1, 2022
Stine Bjerrum Moeller et al. (20 authors)
Journal ArticlePractice GuidelineHuman StudyClinical
Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
repetitive transcranial magnetic stimulation (rTMS)
increase
treatment of difficult-to-treat-depression (DTD)
patients with difficult-to-treat-depression (DTD)
-
sufficient evidence for a weak recommendation
#1
cognitive behavioural analysis system of psychotherapy (CBASP)
increase
treatment of difficult-to-treat-depression (DTD)
patients with difficult-to-treat-depression (DTD)
-
sufficient evidence for a weak recommendation
#2
bright light therapy
no change
treatment of difficult-to-treat-depression (DTD)
patients with difficult-to-treat-depression (DTD)
-
not sufficiently supported by the evidence, but should be considered as good clinical practice
#3
intravenous ketamine/esketamine
no change
treatment of difficult-to-treat-depression (DTD)
patients with difficult-to-treat-depression (DTD)
-
did not find sufficient evidence to recommend
#4
rumination-focused psychotherapy
no change
treatment of difficult-to-treat-depression (DTD)
patients with difficult-to-treat-depression (DTD)
-
did not find sufficient evidence to recommend
#5
cognitive remediation
no change
treatment of difficult-to-treat-depression (DTD)
patients with difficult-to-treat-depression (DTD)
-
did not find sufficient evidence to recommend
#6
Abstract

BACKGROUND: Difficult-to-treat-depression (DTD) is a clinical challenge. The interventions that are well-established for DTD are not suitable or effective for all the patients. Therefore, more treatment options are highly warranted. We formulated an evidence-based guideline concerning six interventions not well-established for DTD in Denmark. METHODS: Selected review questions were formulated according to the PICO principle with specific definitions of the patient population (P), the intervention (I), the comparison (C), and the outcomes of interest (O), and systematic literature searches were performed stepwise for each review question to identify relevant systematic reviews/meta-analyses, and randomized controlled trials. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the methodological quality of the included studies. Clinical recommendations were formulated based on the evidence, the risk-benefit ratio, and perceived patient preferences. RESULTS: We found sufficient evidence for a weak recommendation of repetitive transcranial magnetic stimulation (rTMS) and cognitive behavioural analysis system of psychotherapy (CBASP). The use of bright light therapy in DTD was not sufficiently supported by the evidence, but should be considered as good clinical practice. The interventions should be considered in addition to ongoing antidepressant treatment. We did not find sufficient evidence to recommend intravenous ketamine/esketamine, rumination-focused psychotherapy, or cognitive remediation to patients with DTD. CONCLUSION: The evidence supported two of the six reviewed interventions, however it was generally weak which emphasizes the need for more good quality studies. This guideline does not cover all treatment options and should be regarded as a supplement to relevant DTD-guidelines.

Medical Subject Headings (MeSH)
Antidepressive AgentsCognitive Behavioral TherapyDepressionHumansPsychotherapy
Study Links
Citation Metrics
Total Citations8
Citations/Year2.7
Relative Citation Ratio1.35
NIH Percentile61.2%
Research Impact Scores
APT Score0.50
Related Supplements
Treatment of difficult-to-treat depression - clinical guidel... | Panacea Index